HHS Again Urged To Use March-In Rights To Cut Drug Costs
A slew of advocacy groups levied more pressure on the Biden administration Thursday to use existing executive powers — including taking over the rights of drug patents — to lower the...To view the full article, register now.
Already a subscriber? Click here to view full article